AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ISLAND PHARMACEUTICALS LTD

0.430

-0.010-2.27%

Volume:63.47K

Turnover:27.18K

Market Cap:126.75M

PE:-11.81

High:0.440

Open:0.430

Low:0.425

Close:0.440

52wk High:0.630

52wk Low:0.200

Shares:294.77M

Float Shares:110.76M

Volume Ratio:0.86

T/O Rate:0.06%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.036

EPS(LYR):-0.036

ROE:-95.50%

ROA:-60.12%

PB:9.42

PE(LYR):-11.81

Loading ...

Overview Company News Filings

Island Pharmaceuticals Says Pivotal Marburg Data Secured for Galidesivir FDA Pathway

Island Pharmaceuticals Gets Approval to Cross-Reference Non-Human Primate Study in Marburg-Angola Virus Regulatory Submissions

MT Newswires Live

Island Pharmaceuticals - Receives Loa to Cross-Reference Marburg-Angola Nhp Data in FDA Submissions

THOMSON REUTERS

Island Pharmaceuticals Posts Prelim FY Loss Attributable of A$9.8 Million

Island Pharmaceuticals - FY Prelim Income from Ordinary Activities up 214.6% to A$559,080

THOMSON REUTERS

Island Pharmaceuticals Ltd - no Dividends Paid, Recommended or Declared During Current Financial Period

THOMSON REUTERS

Island Pharmaceuticals Ltd-Preliminary Final Report

THOMSON REUTERS

Island Pharmaceuticals Boosts Galidesivir Supply Amid Ebola Outbreak, Shares Up 4%

MT Newswires Live

Island Pharmaceuticals Ltd - Island Boosts Galidesivir Supply as Ebola Surges

THOMSON REUTERS

Island Pharmaceuticals - Additional Production of Gmp-Grade Galidesivir Commissioned with Pi Health Sciences

THOMSON REUTERS

Island Pharmaceuticals Signs Statement of Work With Texas Biomed to Advance Galidesivir, Shares Hit Six Month High

MT Newswires Live

Island Pharmaceuticals Ltd-texas Biomed Sow Accelerates Pivotal FDA Pathway

THOMSON REUTERS

Insider Sales At Island Pharmaceuticals Landed A Good Price

Simply Wall St.

Island Pharmaceuticals Hits Seven-month High on Galidesivir Approval for Ebola Epidemic

Island Pharmaceuticals Secures Regulatory Approvals for Compassionate Treatment Using Drug Candidate for Uganda Ebola Virus Patients

MT Newswires Live

Island Pharmaceuticals Ltd-galidesivir Approved for Treatment Use in in Ebola Epidemic

THOMSON REUTERS

Island Pharmaceuticals - Galidesivir to be Deployed Within Cy26

THOMSON REUTERS

Island Pharmaceuticals Requests Trading Halt Pending Antiviral Drug Candidate Trial Update

MT Newswires Live

Island Pharmaceuticals Seeks Trading Halt

Island Pharmaceuticals - Trading Halt Pending Announcement on Galidesivir Use in Ebola Clinical Trial in Africa

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/ILA.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ILA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ILA.AU\",,,,,undefined,":{"symbol":"ILA.AU","market":"AU","secType":"STK","nameCN":"ISLAND PHARMACEUTICALS LTD","latestPrice":0.43,"timestamp":1788235251441,"preClose":0.44,"halted":0,"volume":63474,"delay":0,"changeRate":-0.02272727272727275,"nameEN":"ISLAND PHARMACEUTICALS LTD","floatShares":110756995,"shares":294766682,"eps":-0.0364,"marketStatus":"Trading","change":-0.01,"latestTime":"09-01 14:05:58 AEST","open":0.43,"high":0.44,"low":0.425,"amount":27176,"amplitude":0.034091,"askPrice":0.44,"askSize":40159,"bidPrice":0.43,"bidSize":14534,"shortable":3,"etf":0,"ttmEps":-0.0364,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788242400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.44,"openAndCloseTimeList":[[1788220800000,1788242400000]],"volumeRatio":0.864757,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ILA.AU","preClose":0.44,"auctionPrice":0.43,"auctionVolume":1388,"auctionTime":1788220762102,"referenceTime":1788172203092,"auction":1,"marketStatus":"盘前竞价","timestamp":1788220762102}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ILA.AU\",,,,,undefined,":{"symbol":"ILA.AU","floatShares":110756995,"roa":"-60.12%","roe":"-95.50%","lyrEps":-0.0364,"volumeRatio":0.864757,"shares":294766682,"dividePrice":0,"high":0.44,"amplitude":0.034091,"preClose":0.44,"low":0.425,"week52Low":0.2,"pbRate":"9.42","psRate":"448.42","week52High":0.63,"institutionHeld":0,"latestPrice":0.43,"committee":-0.468524,"eps":-0.0364,"divideRate":0,"volume":63474,"delay":0,"ttmEps":-0.0364,"open":0.43,"prevYearClose":0.43,"prevWeekClose":0.44,"prevMonthClose":0.44,"prevQuarterClose":0.38,"fiveDayClose":0.465,"twentyDayClose":0.415,"sixtyDayClose":0.35,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ILA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ILA.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ILA.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663049025","title":"Island Pharmaceuticals Says Pivotal Marburg Data Secured for Galidesivir FDA Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2663049025","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663049025?lang=en_us&edition=fundamental","pubTime":"2026-08-31 09:51","pubTimestamp":1788141090,"startTime":"0","endTime":"0","summary":"BRIEF-Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA PathwayAug 31 -Island Pharmaceuticals LtdILA.AX:PIVOTAL MARBURG DATA SECURED FOR GALIDESIVIR FDA PATHWAYRECEIVES LOA TO CROSS-REFERENCE MARBURG-ANGOLA NHP DATA IN FDA SUBMISSIONSFurther company coverage:ILA.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUE5PYMHC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663641023","title":"Island Pharmaceuticals Gets Approval to Cross-Reference Non-Human Primate Study in Marburg-Angola Virus Regulatory Submissions","url":"https://stock-news.laohu8.com/highlight/detail?id=2663641023","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663641023?lang=en_us&edition=fundamental","pubTime":"2026-08-31 08:54","pubTimestamp":1788137649,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  received authorization to cross-reference a detailed non-human primate natural history study of Marburg-Angola virus in submissions to the US Food and Drug Administration , according to a Monday filing with the Australian bourse.The letter of authorization follows more than six months of negotiations to secure access to the original natural history study, and addresses an information requirement identified by the US FDA, per the filing.Island Pharmaceuticals is advancing galidesivir as a potential medical countermeasure for Marburg virus disease under the FDA's animal rule, which provides a pathway for approval in cases where human efficacy trials are unethical or infeasible.The company said the authorization will provide savings in development time and capital as it will not have to independently recreate an equivalent Marburg natural history program.Marburg virus disease is an often fatal viral illness that causes bleeding inside and outside the body, accordin","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663904098","title":"Island Pharmaceuticals - Receives Loa to Cross-Reference Marburg-Angola Nhp Data in FDA Submissions","url":"https://stock-news.laohu8.com/highlight/detail?id=2663904098","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663904098?lang=en_us&edition=fundamental","pubTime":"2026-08-31 07:02","pubTimestamp":1788130925,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nTUE5PYMHC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662750762","title":"Island Pharmaceuticals Posts Prelim FY Loss Attributable of A$9.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662750762","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662750762?lang=en_us&edition=fundamental","pubTime":"2026-08-26 13:08","pubTimestamp":1787720895,"startTime":"0","endTime":"0","summary":"BRIEF-Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 MillionAug 26 -Island Pharmaceuticals LtdILA.AX:NO DIVIDENDS PAID, RECOMMENDED OR DECLARED DURING CURRENT FINANCIAL PERIODFY PRELIM INCOME FROM ORDINARY ACTIVITIES UP 214.6% TO A$559,080PRELIM FY LOSS ATTRIBUTABLE OF A$9.8 MILLIONFurther company coverage:ILA.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nTUE7GFNJS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662876278","title":"Island Pharmaceuticals - FY Prelim Income from Ordinary Activities up 214.6% to A$559,080","url":"https://stock-news.laohu8.com/highlight/detail?id=2662876278","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662876278?lang=en_us&edition=fundamental","pubTime":"2026-08-26 13:04","pubTimestamp":1787720672,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nTUE7GFNJS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662762272","title":"Island Pharmaceuticals Ltd - no Dividends Paid, Recommended or Declared During Current Financial Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2662762272","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662762272?lang=en_us&edition=fundamental","pubTime":"2026-08-26 13:04","pubTimestamp":1787720672,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nTUE7GFNJS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662762214","title":"Island Pharmaceuticals Ltd-Preliminary Final Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2662762214","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662762214?lang=en_us&edition=fundamental","pubTime":"2026-08-26 13:04","pubTimestamp":1787720672,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nTUE7GFNJS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661532952","title":"Island Pharmaceuticals Boosts Galidesivir Supply Amid Ebola Outbreak, Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661532952","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661532952?lang=en_us&edition=fundamental","pubTime":"2026-08-21 08:43","pubTimestamp":1787272988,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  commissioned an additional production campaign of good manufacturing practice  grade antiviral drug Galidesivir with contract manufacturer PI Health Sciences, according to a Friday Australian bourse filing.The manufacturing is expected to be completed in the fourth quarter, providing up to about 800 treatment courses, per the filing.The company said the additional supply comes as the ongoing Ebola virus Bundibugyo strain outbreak continues to spread rapidly across Central Africa, with Galidesivir expected to be deployed in Uganda during the year, providing an opportunity to generate human efficacy, safety and virological data during an active outbreak.The company's shares rose 4% in recent Friday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661380258","title":"Island Pharmaceuticals Ltd - Island Boosts Galidesivir Supply as Ebola Surges","url":"https://stock-news.laohu8.com/highlight/detail?id=2661380258","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661380258?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:57","pubTimestamp":1787266663,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H1CC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661258387","title":"Island Pharmaceuticals - Additional Production of Gmp-Grade Galidesivir Commissioned with Pi Health Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2661258387","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661258387?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:57","pubTimestamp":1787266663,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H1CC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651162755","title":"Island Pharmaceuticals Signs Statement of Work With Texas Biomed to Advance Galidesivir, Shares Hit Six Month High","url":"https://stock-news.laohu8.com/highlight/detail?id=2651162755","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651162755?lang=en_us&edition=fundamental","pubTime":"2026-07-13 10:13","pubTimestamp":1783908817,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  executed a statement of work  with the Texas Biomedical Research Institute to further advance Galidesivir's Animal Rule development for the treatment of Marburg Virus Disease, according to a Monday Australian bourse filing.Galidesivir is the company's clinical-stage antiviral molecule with a broad spectrum of activity in over 20 RNA viruses, including high-priority threats such as Ebola and Marburg, with the SOW providing the opportunity to advance a complementary Food and Drug Administration-directed dose optimisation study in a further 12 non-human primates.The company's shares rose 10% in recent Monday trade, reaching their highest price since December 2025.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651716150","title":"Island Pharmaceuticals Ltd-texas Biomed Sow Accelerates Pivotal FDA Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2651716150","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651716150?lang=en_us&edition=fundamental","pubTime":"2026-07-13 07:46","pubTimestamp":1783899975,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260712:nTUE3Z46P2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650137767","title":"Insider Sales At Island Pharmaceuticals Landed A Good Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2650137767","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650137767?lang=en_us&edition=fundamental","pubTime":"2026-07-11 04:39","pubTimestamp":1783715995,"startTime":"0","endTime":"0","summary":"While it’s been a great week for Island Pharmaceuticals Limited ( ASX:ILA ) shareholders after stock gained 20...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-ila/island-pharmaceuticals-shares/news/insider-sales-at-island-pharmaceuticals-landed-a-good-price","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-ila/island-pharmaceuticals-shares/news/insider-sales-at-island-pharmaceuticals-landed-a-good-price","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649605315","title":"Island Pharmaceuticals Hits Seven-month High on Galidesivir Approval for Ebola Epidemic","url":"https://stock-news.laohu8.com/highlight/detail?id=2649605315","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649605315?lang=en_us&edition=fundamental","pubTime":"2026-07-07 11:12","pubTimestamp":1783393921,"startTime":"0","endTime":"0","summary":"BUZZ-Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic** Shares of Australia-based Island PharmaceuticalsILA.AXrise as much as 46.7% to A$0.550, hitting their hig","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4N43907F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649167272","title":"Island Pharmaceuticals Secures Regulatory Approvals for Compassionate Treatment Using Drug Candidate for Uganda Ebola Virus Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2649167272","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649167272?lang=en_us&edition=fundamental","pubTime":"2026-07-07 07:42","pubTimestamp":1783381324,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals (ASX:ILA) secured regulatory and ethics approvals for the compassionate use treatment using its Galidesivir drug candidate for patients infected with the Bundibugyo Ebola virus ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649672691","title":"Island Pharmaceuticals Ltd-galidesivir Approved for Treatment Use in in Ebola Epidemic","url":"https://stock-news.laohu8.com/highlight/detail?id=2649672691","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649672691?lang=en_us&edition=fundamental","pubTime":"2026-07-07 07:02","pubTimestamp":1783378945,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUEBRVR0P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649672612","title":"Island Pharmaceuticals - Galidesivir to be Deployed Within Cy26","url":"https://stock-news.laohu8.com/highlight/detail?id=2649672612","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649672612?lang=en_us&edition=fundamental","pubTime":"2026-07-07 07:02","pubTimestamp":1783378945,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUEBRVR0P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648630918","title":"Island Pharmaceuticals Requests Trading Halt Pending Antiviral Drug Candidate Trial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2648630918","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648630918?lang=en_us&edition=fundamental","pubTime":"2026-07-03 11:11","pubTimestamp":1783048272,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  requested a trading halt on the Australian Securities Exchange, pending an update regarding the potential inclusion of its antiviral candidate, galidesivir, in an Ebola clinical trial in Africa, according to a Friday filing with the Australian bourse.The halt will remain in effect until the earlier of the company releasing the update or the commencement of trading on July 7, the filing added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648637488","title":"Island Pharmaceuticals Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2648637488","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648637488?lang=en_us&edition=fundamental","pubTime":"2026-07-03 10:24","pubTimestamp":1783045466,"startTime":"0","endTime":"0","summary":"BRIEF-Island Pharmaceuticals Seeks Trading HaltJuly 3 (Reuters)-Island Pharmaceuticals LtdILA.AX:TRADING HALT PENDING ANNOUNCEMENT ON GALIDESIVIR USE IN EBOLA CLINICAL TRIAL IN AFRICAFurther company coverage:ILA.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nFWN43410R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648763712","title":"Island Pharmaceuticals - Trading Halt Pending Announcement on Galidesivir Use in Ebola Clinical Trial in Africa","url":"https://stock-news.laohu8.com/highlight/detail?id=2648763712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648763712?lang=en_us&edition=fundamental","pubTime":"2026-07-03 10:23","pubTimestamp":1783045394,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nFWN43410R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}]}}